|
Hemeroteca 
|
HIV vaccine may raise risk November 17, 2007 An HIV vaccine made by Merck that failed in clinical trials may have increased the susceptibility of some trial participants to the AIDS virus, researchers reported last week. The findings have left scientists grappling with the problem of how to handle future trials of vaccines that use similar strategies to stimulate an immune response. Mas info en: 
|